Protoporphyrin IX fluorescence contrast in invasive glioblastomas is linearly correlated with Gd enhanced magnetic resonance image contrast but has higher diagnostic accuracy

Journal of Biomedical Optics

Volumn 16, Issue 9, 2011, Pages

  Samkoe, Kimberley S ^a,b   Gibbs Strauss, Summer L ^a   Yang, Harold H ^a   Khan Hekmatyar, S ^b   Jack Hoopes, P ^a,b   O'Hara, Julia A ^a,b   Kauppinen, Risto A ^b   Pogue, Brian W ^a,b  

^a DARTMOUTH COLLEGE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

aminolevulinic acid; fluorescence guided resection; glioblastoma; magnetic resonance imaging; protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; ATHYMIC; CONTRAST-ENHANCED MR; DIAGNOSTIC ACCURACY; EX-VIVO; FLUORESCENCE-GUIDED RESECTION; GLIOBLASTOMAS; GREEN FLUORESCENT PROTEIN; IMAGE CONTRASTS; IN-VIVO; MAGNETIC RESONANCE IMAGES; NUDE MICE; PREDICTIVE POWER; PROTOPORPHYRIN IX; REGIONS OF INTEREST; SENSITIVITY AND SPECIFICITY; TUMOR VASCULARITY;

GADOLINIUM; MAGNETIC RESONANCE IMAGING; MAMMALS; RESONANCE; TUMORS;

FLUORESCENCE;

MUS MUSCULUS;

AMINOLEVULINIC ACID; GADOLINIUM; PROTOPORPHYRIN;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; CHEMISTRY; CYTOCHEMISTRY; DIFFUSION; GLIOBLASTOMA; HUMAN; MALE; METABOLISM; METHODOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; RECEIVER OPERATING CHARACTERISTIC; SPECTROFLUOROMETRY; TUMOR CELL LINE;

AMINOLEVULINIC ACID; ANIMALS; AREA UNDER CURVE; CELL LINE, TUMOR; DIFFUSION; GADOLINIUM; GLIOBLASTOMA; HISTOCYTOCHEMISTRY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, NUDE; PROTOPORPHYRINS; ROC CURVE; SPECTROMETRY, FLUORESCENCE;

EID: 80052533635     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3622754     Document Type: Article

References (19)

1. W. Stummer, A. Novotny, H. Stepp, C. Goetz, K. Bise, and H. J. Reulen, Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients., J. Neurosurg. 93 (6), 1003-1013 (2000). 10.3171/jns.2000.93.6.1003 (Pubitemid 32800611)
2. W. Stummer, U. Pichlmeier, T. Meinel, O. D. Wiestler, F. Zanella, H. J. Reulen, and for the ALA-Glioma Study Group, Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial., Lancet Oncol. 7 (5), 392-401 (2006). 10.1016/S1470-2045(06)70665-9
3. W. Stummer, H. J. Reulen, T. Meinel, U. Pichlmeier, W. Schumacher, J. C. Tonn, V. Rohde, F. Oppel, B. Turowski, C. Woiciechowsky, K. Franz, and T. Pietsch, Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias., Neurosurgery 62 (3), 564-576 (2008). 10.1227/01.neu.0000317304.31579.17
4. W. Stummer, H. J. Reulen, A. Novotny, H. Stepp, and J. C. Tonn, Fluorescence-guided resections of malignant gliomas-an overview., Acta Neurochir [Suppl] 88, 9-12 (2003).
5. W. Stummer, H. Stepp, G. Moller, A. Ehrhardt, M. Leonhard, and H. J. Reulen, Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue., Acta Neurochir. 140 (10), 995-1000 (1998). 10.1007/s007010050206 (Pubitemid 28508688)
6. W. Stummer, S. Stocker, S. Wagner, H. Stepp, C. Fritsch, C. Goetz, A. E. Goetz, R. Kiefmann, and H. J. Reulen, Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence., Neurosurgery 42 (3), 518-525 (1998). 10.1097/00006123-199803000-00017 (Pubitemid 28128737)
7. D. W. Roberts, P. A. Valdes, B. T. Harris, K. M. Fontaine, A. Hartov, X. Fan, S. Ji, S. S. Lollis, B. W. Pogue, F. Leblond, T. D. Tosteson, B. C. Wilson, and K. D. Paulsen, Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between delta-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters., J. Neurosurg. 114 (3), 595-603 (2011). 10.3171/2010.2.JNS091322
8. P. A. Valdes, X. Fan, S. Ji, B. T. Harris, K. D. Paulsen, and D. W. Roberts, Estimation of brain deformation for volumetric image updating in protoporphyrin IX fluorescence-guided resection., Stereotact. Funct. Neurosurg. 88 (1), 1-10 (2010). 10.1159/000258143
9. P. A. Valdes, K. Samkoe, J. A. O'Hara, D. W. Roberts, K. D. Paulsen, and B. W. Pogue, Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model., Photochem. Photobiol. 86 (2), 471-475 (2010). 10.1111/j.1751-1097.2009.00664.x
10. P. A. Valdes, F. Leblond, A. Kim, B. T. Harris, B. C. Wilson, X. Fan, T. D. Tosteson, A. Hartov, K. Erkmen, N. E. Simmons, K. D. Paulsen, and D. W. Roberts, Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker., J. Neurosurg., ePub ahead of print, 115, 1-22 (2011). 10.3171/2011.2.JNS101451
11. M. Hefti, G. von Campe, M. Moschopulos, A. Siegner, H. Looser, and H. Landolt, 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion., Swiss Medical Weekly 138 (11-12), 180-185 (2008).
12. S. Collaud, A. Juzeniene, J. Moan, and N. Lange, On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation., Curr. Med. Chem. 4 (3), 301-316 (2004). 10.2174/1568011043352984 (Pubitemid 38647588)
13. M. Olivo and B. C. Wilson, Mapping ALA-induced PPIX fluorescence in normal brain and brain tumour using confocal fluorescence microscopy., Int. J. Oncol. 25 (1), 37-45 (2004).
14. D. Croteau, L. Scarpace, D. Hearshen, J. Gutierrez, J. L. Fisher, J. P. Rock, and T. Mikkelsen, Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma., Neurosurgery 49 (4), 823-829 (2001). 10.1097/00006123-200110000-00008 (Pubitemid 32927953)
15. S. L. Gibbs-Strauss, J. A. O'Hara, S. Srinivasan, P. J. Hoopes, T. Hasan, and B. W. Pogue, Diagnostic detection of diffuse glioma tumors in vivo with molecular fluorescent probe-based transmission spectroscopy., Med. Phys. 36 (3), 974-983 (2009). 10.1118/1.3075770
16. S. C. Davis, K. S. Samkoe, J. A. O'Hara, S. L. Gibbs-Strauss, H. L. Payne, P. J. Hoopes, K. D. Paulsen, and B. W. Pogue, MRI-coupled fluorescence tomography quantifies EGFR activity in brain tumors., Acad. Radiol. 17 (3), 271-276 (2010). 10.1016/j.acra.2009.11.001
17. S. Mori and P. C. M. Van Zijl, Diffusion weighting by the trace of the diffusion tensor within a single scan., Magn. Reso. Med. 33 (1), 41-52 (1995). 10.1002/mrm.1910330107
18. O. Tynninen, H. J. Aronen, M. Ruhala, A. Paetau, K. Von Boguslawski, O. Salonen, J. Jskelinen, and T. Paavonen, MRI enhancement and microvascular density in gliomas: correlation with tumor cell proliferation., Invest. Radiol. 34 (6), 427-434 (1999). 10.1097/00004424-199906000-00007 (Pubitemid 29239360)
19. S. Miyatake, T. Kuroiwa, Y. Kajimoto, M. Miyashita, H. Tanaka, and M. Tsuji, Fluorescence of non-neoplastic, magnetic resonance imaging-enhancing tissue by 5-aminolevulinic acid: case report., Neurosurgery 61 (5), E1101-1103; discussion E1103-1104 (2007). 10.1227/01.neu.0000303209.38360.e6